Showing results (431-440 of 668) with videos related to

Sort By:
Pageof 67
Hemasphere|April 21, 2021
Low-Risk Essential Thrombocythemia: A Comprehensive ReviewAndrew J Robinson, Anna L Godfrey
Hemasphere|August 14, 2025
Inflammatory signaling in the pathogenesis of acute myeloid leukemiaArtemis Margrith Baumann, Jana Maria Ellegast
Hemasphere|July 17, 2025
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myelomaOla Landgren, Noa Biran, Elizabeth K O'Donnell, et al.
Hemasphere|July 14, 2025
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapyJort J van der Schans, Paresh Vishwasrao, Renée Poels, et al.
Hemasphere|July 25, 2025
Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequencesSimon M Krauß, Eva Telzerow, Daniel Richter, et al.
Hemasphere|July 28, 2025
Open or closed? Understanding the molecular mechanisms and clinical implications of ADAMTS13's conformationQuintijn Bonnez, Karen Vanhoorelbeke
Hemasphere|August 20, 2025
Syntenin inhibition impairs stroma-tumor communication in multiple myeloma and improves bortezomib treatment efficiencyChenggong Tu, Raphael Leblanc, Arne Van der Vreken, et al.
Hemasphere|June 5, 2025
New horizons in the pharmacological management of venous thromboembolismAndreas Verstraete, Quentin Van Thillo, Thomas Vanassche, et al.
Hemasphere|March 4, 2024
Analysis of immunoglobulin/T-cell receptor repertoires by high-throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphomaVictor Bobée, Mathieu Viennot, Vinciane Rainville, et al.
Hemasphere|April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplantPrashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Pageof 67